Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your ...

Shares of Humana Inc. rallied 3.94% to $247.34 Monday, on what proved to be an all-around positive trading session for the ...

Furthermore, Humana continues to face pressure from rising medical costs, and its benefits expense ratio increased by 270 bps y-o-y to 89%, weighing on its stock performance. Our detailed analysis ...

The company's recent financial performance has been mixed. While Humana has maintained a solid ... HUM appears on our undervalued or overvalued stock lists. These tools provide a clearer picture ...

Despite these developments, Humana's stock performance remained flat over the past week. During the same period, broader markets saw gains, bolstered by strong earnings from major tech companies.

Shares of Humana and other health insurers fell Thursday after the Centers for Medicare & Medicaid Services said it plans to ...

Humana stock closed at $246.49 ... The company said it also is focused on improving its performance to regain its star rating. Humana, one of the biggest providers of Medicare Advantage coverage ...

Sarah James, a stock analyst with Cantor Fitzgerald ... The lower rating won’t affect Humana’s performance until 2026, but the company said it was “disappointed with its performance and ...

Humana said that just a quarter of its members are enrolled in a 4-star or better plan for 2025, down from more than 90% in 2024. The company said it is disappointed in its performance and ...